Free tool
FAERS Monitor: Advil Congestion Relief
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 022565 or its brand name (Advil Congestion Relief, Ibuprofen, Phenylephrine Hydrochloride). Reports on generic versions are filed under their own applications.
Reports
998
Serious
15
2% of reports
Hospitalization
6
Death reported
2
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- product use in unapproved indication289
- drug ineffective257
- drug effective for unapproved indication255
- drug effect incomplete91
- therapeutic product effect incomplete67
- therapeutic response unexpected49
- drug ineffective for unapproved indication48
- pre-existing condition improved45
- somnolence42
- product use issue28
- drug effect less than expected24
- feeling abnormal19
- condition aggravated15
- headache15
- hypersensitivity14
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2015 | 218 |
| 2016 | 131 |
| 2017 | 79 |
| 2018 | 23 |
| 2019 | 43 |
| 2020 | 11 |
| 2021 | 456 |
| 2022 | 15 |
| 2023 | 7 |
| 2024 | 6 |
| 2025 | 4 |
| 2026 | 5 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,053,161 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| drug effective for unapproved indicationSignal | 255 | 185.1 | 166.4 | 46,161 |
| pre-existing condition improvedSignal | 45 | 153.0 | 114.9 | 6,599 |
| drug effect incompleteSignal | 91 | 52.9 | 43.5 | 4,581 |
| drug effect less than expectedSignal | 24 | 34.2 | 23.0 | 740 |
| product use in unapproved indicationSignal | 289 | 24.6 | 22.3 | 6,590 |
| therapeutic response unexpectedSignal | 49 | 23.0 | 17.5 | 1,012 |
| therapeutic product effect incompleteSignal | 67 | 19.9 | 15.8 | 1,185 |
| drug ineffective for unapproved indicationSignal | 48 | 18.4 | 14.0 | 776 |
| somnolenceSignal | 42 | 4.4 | 3.3 | 108 |
| drug ineffectiveSignal | 257 | 4.1 | 3.7 | 642 |
| product use issueSignal | 28 | 3.1 | 2.2 | 39 |
| feeling abnormal | 19 | 1.7 | 1.1 | 5 |
| hypersensitivity | 14 | 1.6 | 0.9 | 3 |
| condition aggravated | 15 | 1.0 | 0.6 | 0 |
| headache | 15 | 0.5 | 0.3 | 7 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.